The mortality of lung cancer is surprising, even though the development of different
treatments and diagnosis methods. Besides, non-small cell lung cancer (NSCLC) takes a …

Lung cancer represents one of the most common neoplasms and the main cause of cancer‑
associated death worldwide. Its relationship with different risk factors such as tobacco, which …

Gliomas, particularly high-grade gliomas, represent the most common and aggressive
tumors of the CNS and are still burdened by high mortality and a very poor prognosis …

As one of the most reliable and significant indicators, Chronic Obstructive Pulmonary
Disease (COPD) becomes a robust predictor of lung cancer early detection, the world's …

Major advances in the diagnosis and treatment of non-small cell lung cancer (NSCLC) have
resulted in a sharp decline in associated mortality rates, thereby propelling NSCLC to the …

Simple Summary Non-small-cell lung cancers (NSCLCs) are commonly diagnosed
malignancies with poor prognosis. Kirsten rat sarcoma virus (KRAS) mutations are often …

Non-small cell lung cancer is a heterogeneous disease and molecular characterisation
plays an important role in its clinical management. Next-generation sequencing-based …

Abstract Background In 2016, the International Consortium for Health Outcomes
Measurement (ICHOM) defined an international consensus recommendation of the most …

Next-generation sequencing (NGS) has revolutionized the field of genomics and is rapidly
transforming clinical diagnosis and precision medicine. This advanced sequencing …

Insertions in the epidermal growth factor receptor (EGFR) exon 20 (Ex20Ins) are the third
most incident mutations in non-small cell lung cancer (NSCLC). The hypervariable nature of …